Investing
Morning Analyst Calls Briefing for Monday, November 14, 2022
Published:
This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> Advanced Micro (AMD) upgraded to Buy from Neutral at UBS; tgt raised to $95
> Advanced Micro (AMD) upgraded to Outperform from Neutral at Robert W. Baird; tgt raised to $100
> Dominion Energy (D) upgraded to Neutral from Sell at Goldman; tgt lowered to $69
> MacroGenics (MGNX) upgraded to Outperform from Market Perform at BMO Capital Markets; tgt raised to $16
> Medical Properties Trust (MPW) upgraded to Buy from Neutral at BofA Securities; tgt raised to $16
> Occidental Petro (OXY) upgraded to Equal Weight from Underweight at Wells Fargo; tgt raised to $74
> Veris Residential (VRE) upgraded to Neutral from Underperform at BofA Securities; tgt raised to $18
Downgrades:
> Algonquin Power & Utilities (AQN) downgraded to Hold from Buy at Desjardins
> Algonquin Power & Utilities (AQN) downgraded to Market Perform from Outperform at BMO Capital Markets; tgt lowered to $11
> Algonquin Power & Utilities (AQN) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt lowered to $12
> Archaea Energy (LFG) downgraded to Equal Weight from Overweight at Wells Fargo; tgt $26
> CGI Group (GIB) downgraded to Hold from Buy at Societe Generale
> Chart Industries (GTLS) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $148
> CytomX Therapeutics (CTMX) downgraded to Market Perform from Outperform at BMO Capital Markets; tgt lowered to $2.60
> Dr. Reddy’s (RDY) downgraded to Underperform from Neutral at Credit Suisse
> EQRx (EQRX) downgraded to Underweight from Neutral at JP Morgan
> Essex Property (ESS) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $233
> Global Payments (GPN) downgraded to Neutral from Outperform at Robert W. Baird; tgt lowered to $118
> Grainger (GWW) downgraded to Peer Perform from Outperform at Wolfe Research
> Hasbro (HAS) downgraded to Underperform from Buy at BofA Securities; tgt lowered to $42
> Lyell Immunopharma (LYEL) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt lowered to $7
> NETSTREIT (NTST) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $21
> Neurocrine Biosciences (NBIX) downgraded to In-line from Outperform at Evercore ISI; tgt lowered to $130
> NIO (NIO) downgraded to Hold from Buy at China Renaissance; tgt lowered to $12.30
> Orsted A/S (DNNGY) downgraded to Neutral from Buy at Goldman
> Sabra Health Care REIT (SBRA) downgraded to Underperform from Neutral at BofA Securities; tgt lowered to $13
> Spirit Realty Capital (SRC) downgraded to Neutral from Buy at BofA Securities; tgt raised to $43
> Teleperformance (TLPFY) downgraded to Buy from Conviction Buy at Goldman
> Teva Pharma (TEVA) downgraded to Underweight from Neutral at JP Morgan; tgt lowered to $10
Others:
> Bunzl PLC (BZLFY) assumed with a Neutral at Credit Suisse
> Cboe Global Markets (CBOE) initiated with a Neutral at Redburn
> Intertek Group (IKTSY) assumed with an Outperform at Credit Suisse
> Janux Therapeutics (JANX) initiated with an Outperform at William Blair
> NASDAQ (NDAQ) initiated with a Neutral at Redburn
> Prime Medicine (PRME) initiated with a Buy at Jefferies; tgt $25
> Prime Medicine (PRME) initiated with a Neutral at Goldman; tgt $22
> Prime Medicine (PRME) initiated with an Equal-Weight at Morgan Stanley; tgt $23
> Prime Medicine (PRME) initiated with an Overweight at JP Morgan; tgt $27
> Swiss Life (SZLMY) assumed with a Neutral at Credit Suisse
Research calls posted earlier this morning are available here.
Essential Tips for Investing (Sponsored)
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
